Respiratory Syncytial Virus Diagnostics Market Analysis By Product (Direct Fluorescent Antibody (DFA), Rapid Antigen Diagnostic Tests (RADTs), Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry), By End-use (Hospitals, Laboratory, Clinics, Homecare) And Segment Forecasts To 2022

Published: Jan, 2016 | Pages: 82 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

Global Respiratory Syncytial Virus (RSV) diagnostics market is expected to reach USD 1.2 billion by 2022, according to a new study by Grand View Research Inc. Increasing neonatal population suffering from respiratory conditions including RSV infections and supportive initiatives for diagnosis of newborns by the healthcare providers are expected to be vital impact rendering drivers for RSV diagnostics market.

According to the statistics provided by the WHO, hospitalization of over 150,000 children (below the age of five) and about 14,000 deaths in geriatric patients occurred in the U.S. in 2014 due to RSV infections. This is anticipated to trigger demand for testing of these conditions over the forecast period.

Furthermore, the global birth rate as of 2014 is 18.7 births per 1,000 individuals, which is predicted to increase the infant population substantially over the next seven years. According to the statistics, it is estimated that about 134.2 million births took place in 2014, which are prone to RSV infections and require diagnosis, thus forming a large market base.

In 2010, Save Babies Through Screening Foundation (SBTS) entered in a partnership with World Solutions Against Infectious Disease (WSAID) as an attempt to promote higher screening of newborns for infectious diseases, metabolic disorders, and hearing disabilities.

Further key findings from the study suggest:

Chromatographic immunoassay technology based products are expected to witness the fastest growth at a CAGR above 10.0% over the next seven years owing to their higher specificity than molecular diagnostic products. The commercially available test kits include Binax Now RSV, QuickLab RSV Test, Remel Xpect, and RSV Respi-Strip.

Hospitals are predicted to dominate the RSV diagnostics market followed by home care. Together, they are expected to contribute over 50.0% of the market share in 2022. Increasing demand for home care diagnostic devices by patients is anticipated to drive growth of the segment over the next seven years.

North America is anticipated to dominate the market and contribute a revenue share of over 40.0% by 2022. Rising awareness among the population base and favorable initiatives by the government agencies such as the WHO, PAHO, and WSAID to initiate and implement newborn screening are expected to drive growth.

Key players of the market include Alere Inc., EMD Millipore, BD and Company, Ortho Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific Inc. CLIA waiver and launch of RSV assays by companies like Roche Diagnostics, Becton Dickinson and Company, and Alere Inc. are expected to boost market growth over the forecast period.

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Respiratory Syncytial Virus Diagnostics Market- Industry Snapshot and Key Buying Criteria, 2014
Chapter 3. Global Respiratory Syncytial Virus Diagnostics (RSV) Market Industry Outlook
3.1. Respiratory Syncytial Virus Diagnostics Market: Segmentation
3.2. Respiratory Syncytial Virus Diagnostics Market: Size And Growth Prospects
3.3. Respiratory Syncytial Virus Diagnostics Market: Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. Respiratory Syncytial Virus Diagnostics Company Market Share, 2014
3.7. Respiratory Syncytial Virus Diagnostics Market: PESTEL Analysis, 2014
3.8. Respiratory Syncytial Virus Diagnostics Technology Overview
Chapter 4. Global Respiratory Syncytial Virus Diagnostics (RSV) Market Product Outlook
4.1. Respiratory Syncytial Virus Diagnostics Market Share, By Product, 2014 & 2022
4.2. Direct Fluorescence Antibody (DFA) Method
4.2.1. Direct Fluorescence Antibody (DFA) Method Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.3. Rapid Antigen Diagnostic Test(RADTs)
4.3.1. Rapid Antigen Diagnostic Test (RADTs) Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.4. Molecular Diagnostics
4.4.1. Molecular Diagnostics Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.5. Chromatographic Immunoassay
4.5.1. Chromatographic Immunoassay Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.6. Diagnostic Imaging
4.6.1. Diagnostic Imaging Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.7. Gel Microdroplets
4.7.1. Gel Microdroplets Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.8. Flow Cytometry
4.8.1. Flow Cytometry Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.9. Others
4.9.1. Other Market Estimates And Forecasts, 2012 - 2022 (USD Million)
Chapter 5. Global Respiratory Syncytial Virus Diagnostics (RSV) End-use Outlook
5.1. Respiratory Syncytial Virus Diagnostics Market Share, By End-use, 2014 & 2022
5.2. Hospitals
5.2.1. Hospitals Based RSV Diagnostics Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.3. Laboratory
5.3.1. Laboratory Based RSV Diagnostics Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.4. Clinics
5.4.1. Clinics Based RSV Diagnostics Market Estimates And Forecasts, 2012 - 2022 (USD Million)
5.5. Homecare
5.5.1. Homecare Based RSV Diagnostics Market Estimates And Forecasts, 2012 - 2022 (USD Million)
Chapter 6. Global Respiratory Syncytial Virus Diagnostics Market Regional Outlook
6.1. Respiratory Syncytial Virus Diagnostics Market Share, By Region, 2014 & 2022
6.2. North America
6.2.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product, (USD Million), 2012 - 2022
6.2.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use, (USD Million), 2012 - 2022
6.2.2.1. U.S. Estimates and Forecasts
6.2.2.2. Canada Estimates and Forecasts
6.3. Europe
6.3.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product (USD Million), 2012 - 2022
6.3.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use (USD Million), 2012 - 2022
6.3.2.1. UK Estimates and Forecasts
6.3.2.2. Germany Estimates and Forecasts
6.3.2.3. France Estimates and Forecasts
6.3.2.4. Spain Estimates and Forecasts
6.3.2.5. Italy Estimates and Forecasts
6.4. Asia Pacific
6.4.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product (USD Million), 2012 - 2022
6.4.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use (USD Million), 2012 - 2022
6.4.2.1. Japan Estimates and Forecasts
6.4.2.2. China Estimates and Forecasts
6.4.2.3. India Estimates and Forecasts
6.5. Latin America
6.5.1. Respiratory Syncytial Virus Diagnostics Estimates And Forecasts, By Product (USD Million), 2012 - 2022
6.5.2. Respiratory Syncytial Virus Diagnostics Estimates And Forecasts, By End-use (USD Million), 2012 - 2022
6.5.2.1. Brazil Estimates and Forecasts
6.5.2.2. Mexico Estimates and Forecasts
6.5.2.3. Argentina Estimates and Forecasts
6.5.2.4. Peru Estimates and Forecasts
6.6. MEA
6.6.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product (USD Million), 2012 - 2022
6.6.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use (USD Million), 2012 - 2022
6.6.2.1. South Africa Estimates and Forecasts
6.6.2.2. Saudi Arabia Estimates and Forecasts
Chapter 7. Competitive Landscape
7.1. Becton Dickinson and Company
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Novartis Diagnostics
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Abbott Laboratories
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Ortho Clinical Diagnostics
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Thermo Fisher Scientific Inc.
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Bio-Rad Laboratories Inc.
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Hoffmann La Roche Ltd.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. BioMerieux
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. DiaSorin SPA
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. EMD Millipore
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Quidel Corporation
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives
7.12. Alere Inc.
7.12.1. Company Overview
7.12.2. Financial Performance
7.12.3. Product Benchmarking
7.12.4. Strategic Initiatives
7.13. Coris BioConcept
7.13.1. Company Overview
7.13.2. Financial Performance
7.13.3. Product Benchmarking
7.13.4. Strategic Initiatives
7.14. Fast-track Diagnostics
7.14.1. Company Overview
7.14.2. Financial Performance
7.14.3. Product Benchmarking
7.14.4. Strategic Initiatives
7.15. Quest Diagnostics
7.15.1. Company Overview
7.15.2. Financial Performance
7.15.3. Product Benchmarking
7.15.4. Strategic Initiatives

List of Tables

TABLE 1 Respiratory Syncytial Virus Diagnostics Market - Industry Summary & Key Buying Criteria, 2012 - 2022
TABLE 2 RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 3 RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 4 RSV diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 5 Respiratory Syncytial Virus Diagnostics Market - Key Market Driver Analysis
TABLE 6 Country-wise birth rate
TABLE 7 Respiratory Syncytial Virus Diagnostics Market - Key Market Restraint Analysis
TABLE 8 Age distribution for positive cases of Respiratory Syncytial Virus infection in Brazil
TABLE 9 North America RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 10 North America chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 11 North America RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 12 U.S. RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 13 U.S. chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 14 U.S. RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 15 Canada RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 16 Canada chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 17 Canada RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 18 Europe RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 19 Europe chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 20 Europe RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 21 UK RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 22 UK chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 23 UK RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 24 Germany RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 25 Germany chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 26 Germany RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 27 France RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 28 France chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 29 France RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 30 Spain RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 31 Spain chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 32 Spain RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 33 Italy RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 34 Italy chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 35 Italy RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 36 Asia Pacific RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 37 Asia Pacific chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 38 Asia Pacific RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 39 Japan RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 40 Japan chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 41 Japan RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 42 China RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 43 China chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 44 China RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 45 India RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 46 India chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 47 India RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 48 Latin America RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 49 Latin America chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 50 Latin America RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 51 Brazil RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 52 Brazil chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 53 Brazil RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 54 Mexico RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 55 Mexico chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 56 Mexico RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 57 Argentina RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 58 Argentina chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 59 Argentina RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 60 Peru RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 61 Peru chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 62 MEA RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 63 MEA chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 64 MEA RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 65 South Africa RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 66 South Africa chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 67 South Africa RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 68 Saudi Arabia RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 69 Saudi Arabia chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 70 Saudi Arabia RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)